Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Price-to-book ratio
3Y CAGR
-16.6%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.62 | -9.7% |
| 2024 | 1.79 | -59.5% |
| 2023 | 4.42 | +58.7% |
| 2022 | 2.79 | -48.1% |
| 2021 | 5.37 | +137.1% |
| 2020 | -14.47 | +39.8% |
| 2019 | -24.02 | - |